Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review

BMJ Case Rep. 2013 Jun 26:2013:bcr2013009803. doi: 10.1136/bcr-2013-009803.

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterised by chronic cholestasis usually associated with antimitochondrial antibodies. Moreover, several types of antinuclear antibodies have been associated with primary biliary cirrhosis. We describe an 83-year-old man, in whom the exploration of a chronic cholestasis led to the diagnosis of primary biliary cirrhosis despite negative antimitochondrial antibodies, regarding the presence of anti-gp210 antibodies. Found in 25% of patients, these antinuclear antibodies must be sought before a strong suspicion of primary biliary cirrhosis with antimitochondrial antibodies negative, as they are highly specific of the disease. They are generally associated with a more aggressive form of PBC.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antibodies, Antinuclear / immunology*
  • Humans
  • Liver Cirrhosis, Biliary / diagnosis*
  • Liver Cirrhosis, Biliary / immunology
  • Male
  • Nuclear Pore Complex Proteins / immunology*

Substances

  • Antibodies, Antinuclear
  • NUP210 protein, human
  • Nuclear Pore Complex Proteins